Andreas Wicki is Chief Executive Officer of HBM Healthcare Investments AG, Europe’s largest private equity focused investment company dedicated to life sciences. Prior to this role, from 1990-1998, he was co-owner and Chief Executive Officer of ANAWA Laboratorien AG and Clinserve AG, two life sciences CRO companies which he then sold to MDS Inc., a major life sciences services and clinical research organization. After the acquisition, from 1998-2001, he was Senior Vice President of the European Analytical Operations at MDS Inc., which allowed him to become more active in analyzing, selecting, and financing biotech and medtech companies. Dr. Wicki holds an MSc and PhD in chemistry and biochemistry from the University of Bern, Switzerland. He currently serves on the Board of Directors of Buchler GmbH, HBM BioCapital Ltd., HBM Healthcare Investments (Cayman) Ltd., Vitaeris Inc., Harmony Biosciences LLC, and Pacira Pharmaceuticals Inc. Andreas Wicki is Chief Executive Officer of HBM Healthcare Investments AG, Europe’s largest private equity focused investment company dedicated to life sciences. Prior to this role, from 1990-1998, he was co-owner and Chief Executive Officer of ANAWA Laboratorien AG and Clinserve AG, two life sciences CRO companies which he then sold to MDS Inc., a major life sciences services and clinical research organization. After the acquisition, from 1998-2001, he was Senior Vice President of the European Analytical Operations at MDS Inc., which allowed him to become more active in analyzing, selecting, and financing biotech and medtech companies. Dr. Wicki holds an MSc and PhD in chemistry and biochemistry from the University of Bern, Switzerland. He currently serves on the Board of Directors of Buchler GmbH, HBM BioCapital Ltd., HBM Healthcare Investments (Cayman) Ltd., Vitaeris Inc., Harmony Biosciences LLC, and Pacira Pharmaceuticals Inc.

Oncology